News

CPAP therapy reduces risk for repeat revascularization after PCI

10.03.20151729

Untreated obstructive sleep apnea was associated with an increased risk for repeat revascularization after percutaneous coronary intervention, while continuous positive airway pressure therapy reduced that risk, according to study results.

Paroxetine improves cardiac function in mice after myocardial infarction

05.03.20151676

After noticing that paroxetine, a selective serotonin reuptake inhibitor normally used to treat depression, stopped the progression of heart failure in mice, researchers have concluded that the drug could be reclassified for use in humans, investigators wrote in Science Translational Medicine.

Coffee drinking linked to lower subclinical atherosclerosis

04.03.20152151

Light to moderate coffee drinking – less than 5 cups per day – is associated with decreased coronary artery calcium, and thus decreased risk of cardiovascular disease, according to an analysis of a large cohort published online March 2 in Heart.

Study: No benefit from anticoagulant use in Beh?et’s disease

03.03.20151623

Patients with vascular manifestations of Beh?et’s disease who received treatment with anticoagulants did not benefit from the therapy given in addition to immunosuppressant drugs, according to results from study of practices in Turkish rheumatology clinics.

Boehringer Ingelheim files BLA for antidote to dabigatran

02.03.20151679

Boehringer Ingelheim announced that it has submitted a biologics license application to the FDA requesting an accelerated approval pathway for idarucizumab, an antidote to dabigatran.

Serious cardiac complications in coronary spasm provocation tests using acetylcholine or ergonovine: analysis of 21 512 patients from the diagnosis procedure combination database in Japan

28.02.20151789

This retrospective cohort study suggested that acetylcholine (ACH) tests were associated with a higher rate of cardiac complications than ergonovine (ER) tests.

Statin use may reduce risk for liver cancer

27.02.20151604

The use of statins decreased the risk for primary liver cancer, especially in patients with liver disease and diabetes, according to newly published data.